期刊文献+

沙培林瘤腔内注射治疗脑胶质瘤疗效观察

下载PDF
导出
摘要 目的探讨沙培林瘤腔内注射治疗脑胶质瘤的疗效。方法自2000年1月至2004年1月对36例脑胶质瘤病人于手术切除肿瘤后,放置Ommaya囊,瘤腔内注射沙培林治疗。4次为一疗程,定期复查CT随诊,可重复治疗2~3疗程。结果病人反应轻微,耐受性好。CT复查见残余及复发的肿瘤液化、坏死。随访8月~4.5年,存活29例,术后3年以上者21例,2年以上者26例。结论该疗法安全可靠、操作简单,应用于脑胶质瘤术后的病人,可延长其生存期,提高生存质量。
出处 《中国临床神经外科杂志》 2006年第5期308-309,共2页 Chinese Journal of Clinical Neurosurgery
  • 相关文献

参考文献5

  • 1Salcman M,Scholtz H,Kaplan RS,et al.Long-ferm survival in patients with malignant astrocytoma[J].Neurosurgery,1994,34:213~217.
  • 2Okamoto M,Ohe G,Oshikawa T,et al.Enhancement of anti-cancer immunity by a lipoteichoicacid-related molecule isolated from a penicillin killed group A streptococcus[J].Cancer Immunol Immunother,2001,50(8):408~416.
  • 3赵长地,孔姣,聂振明.OK432治疗脑胶质瘤研究进展[J].肿瘤防治杂志,2004,11(11):1210-1212. 被引量:2
  • 4赵长地,颞振明,卢尚佩.沙培林对鼠脑胶质瘤抑癌作用的实验研究[J].临床神经外科杂志,2004,1(3):104-105. 被引量:5
  • 5Fujisawa K,Kanno T,Yokoi K,et al.Antitumor effects of direct intratumor administration of OK-432 on maligant glioma:basic and clinical observation[J].No Shinkei Geka,1991,19(3):241~246.

二级参考文献15

  • 1[4]Fukisawa K,Kanno T,Yokoi,et al.Antitumor effect of directintra-tumor adminitratipn of OK-432 on malignant glioma glioma:basic and clinical observationf.No-Shinkei-Geka,1991,19:241
  • 2Shibata M. Nezu T. Fujisaki S, et al. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer[J]. Dig Surg,2002.19(4):255-260.
  • 3Uehara K, Ichida I, Sugahara S, et al. Systemic administration of liposomeencapsulated OK432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN gammaproducing hepatic lymphocytes[J]. J Gastroenterol Hepatol,2002. 17(1) :81-90.
  • 4Okamoto M, Ohe G, Oshikawa T, et al. Enhancement of anti cancer immunity by a lipoteichoicacid molecule isolated from a penicillin killed groug A streptococcus[J]. Cancer Immunol Im munother.2001.50(8):408-416.
  • 5Wang X. Fujimoto T, Zhang B, et al. Streptococcal preparation OK432 enhances the antitumor activity of CPT-11 by increasing Th1-cytokine production in mice[J]. Anticancer Res, 2001,1(4A) :2505-2510.
  • 6Wongkajornsilp A, Luankosolchai R A, Huahprasert S, et al.The observation of inmmunosuppress derived from cultured tumor cell and its partial neutralization with OK432[J]. J Med AssocThai,2001,84(2):212-222.
  • 7Shibata S, Morik M, Moriyama T, et al. Randomized Controlled study of the effect of adjuvant immunotherapy with pici band on 51 malignant gliomas[J]. Surg Neurol, 1987. 27(3):259-263
  • 8Numa Y, KawamotoK, Matsumura H. Multidisciplinarythera py using interferon and immunological evaluation for glioma patients: two color analysis of T cell subsets[J]. No Shinkei Ge ka. 1991.19(2): 121 - 128.
  • 9Yamamoto K, Tanaka R, Yoshida S. et al. Effects of OK432 on the proliferation and cytotoxicity of lymphokine activated killer (LAK) cells[J]. J Immunother,1999,22(1):33-40.
  • 10Fujisawa K, Kanno T, Yokoi K, et al. Antitumor effects of direct inter-tumor administration of OK432 on malignant glioma:basic and clinical observation[J]. No Shinkei Geka, 1991.19(3):241-246.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部